Office of the Commissioner of Lobbying of Canada
Registry of Lobbyists

Monthly Communication Report

360912-653220

Corporation: Gilead Sciences Canada
Associated registration: 959600-360912-16
Communication date: 2025-10-22
Posted date: 2025-11-15

Designated Public Office Holders who participated in the communication: Shahad Khalladi, Senior Policy Advisor
Health Canada (HC)

Bryn Savage, Policy Advisor
Health Canada (HC)

Justine Frame, Special Assistant, Policy
Health Canada (HC)

Sandenga Yeba, Director of Policy and Deputy Chief of Staff
Health Canada (HC)
 
List of Details
Subject matter Detail
Health, Science and Technology Canada Agency for Drugs and Technologies in Health (CADTH) as it relates to health economics assessment and recommendations made on new medicines.
Aboriginal Affairs, Health Federal Government First Nations and Inuit Health Branch program with respect to health services. Federally-funded Public Drug Plans, with respect to reimbursement for drug products for federal plan beneficiaries.
Economic Development, Employment and Training, Health, Industry, Intellectual Property, Research and Development, Science and Technology Innovation Agenda, particularly with respect to initiatives to support and attract investments in the life sciences sector
Health, Industry, Intellectual Property, International Trade, Research and Development, Science and Technology Patent Act Regulations as they relate to the regulation of intellectual property for therapeutic products, specifically the Patented Medicines (Notice of Compliance) Regulations Patented Medicine Prices Review Board (PMPRB) Regulations with regard to reporting requirements, pricing, guidelines and dispute resolution.
Aboriginal Affairs, Health, Immigration, Industry, Research and Development, Science and Technology Policy and Programs Health Canada and Public Health Agency of Canada policies and programs to prevent and treat HIV and eliminate hepatitis as a public health threat by 2030, as part of Canada's commitments under the Global Viral Hepatitis Strategy and therapeutic efforts against the fight for COVID-19.
 
Responsible Officer who filed this communication report: Paul Petrelli
 
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication.

The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.
 

Date Modified: